Expression of concern
The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer
Paper Information
Record ID:
31311
Author(s):
Journal:
Publication Date:
March 21, 2006
Retraction Date:
August 02, 2021
(4.3 years years ago)
Subjects:
Broad Categories:
Biology
Biology
Institutions:
- Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
- Department of Biostatistics and Applied Mathematics, University of Texas M.D. Anderson Cancer Center, Houston, Texas
- Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
- Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa
Country:
🇺🇸 United StatesArticle Type:
Publisher:
American Association for Cancer Research
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reason:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1158/1078-0432.CCR-21-2121Citations (171)
171
Total Citations16
Post-Retraction(9.4%)
153
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
4
Within 1 year
5
After 2+ years
1416
Days since retraction (latest)
Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis
Honglei Jia, Qingyu Zhang, Fanxiao Liu et al. (4 authors)
Archives of Gynecology and Obstetrics
Published: Dec 2016
36 citations
36 citations
1687 days before retraction
Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway
Bo Li, Shaoxi Cai, Yi Zhao et al. (11 authors)
Oncotarget
Open Access
Published: Nov 2016
25 citations
25 citations
1729 days before retraction
Anacardic acid inhibits gelatinases through the regulation of Spry2, MMP-14, EMMPRIN and RECK
Jyotsna Nambiar, Chinchu Bose, Meera Venugopal et al. (7 authors)
Experimental Cell Research
Published: Oct 2016
18 citations
18 citations
1752 days before retraction
MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
M. Caroline Vos, Eva Hollemans, Nicole P. M. Ezendam et al. (11 authors)
Journal of Ovarian Research
Open Access
Published: Sep 2016
39 citations
39 citations
1795 days before retraction
Solasodine Induces Apoptosis, Affects Autophagy, and Attenuates Metastasis in Ovarian Cancer Cells
Xiao-Huang Xu, Lele Zhang, Guosheng Wu et al. (8 authors)
Planta Medica
Published: Jul 2016
26 citations
26 citations
1832 days before retraction
Molecular Portrait of Oral Tongue Squamous Cell Carcinoma Shown by Integrative Meta-Analysis of Expression Profiles with Validations
Soundara Viveka Thangaraj, Vidyarani Shyamsundar, Arvind Krishnamurthy et al. (7 authors)
PLoS ONE
Open Access
Published: Jun 2016
152 citations
152 citations
1880 days before retraction
Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain
Laura Divine, Nora T. Kizer, Andrea R. Hagemann et al. (9 authors)
Gynecologic Oncology
Open Access
Published: May 2016
31 citations
31 citations
1912 days before retraction
Tumor microenvironment: The culprit for ovarian cancer metastasis?
Zhongyue Luo, Qiu Wang, Wayne Bond Lau et al. (16 authors)
Cancer Letters
Published: Apr 2016
177 citations
177 citations
1920 days before retraction
Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer
M. Caroline Vos, A.A.M. van der Wurff, Johan Bulten et al. (8 authors)
Diagnostic Pathology
Open Access
Published: Apr 2016
20 citations
20 citations
1948 days before retraction
Integrin-linked kinase activity modulates the pro-metastatic behavior of ovarian cancer cells
Lana Bruney, Yueying Liu, Anne Grisoli et al. (5 authors)
Oncotarget
Open Access
Published: Mar 2016
28 citations
28 citations
1978 days before retraction
Differential Associations of MMP-2 and MMP-14 with Stromal Amounts and T lymphocyte Presence in Ovarian Cancer
M. Caroline Vos, Elise M. Bekers
Journal of Molecular and Genetic Medicine
Open Access
Published: Jan 2016
1 citation
1 citation
2040 days before retraction
High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation
Danielle L. Bourgeois, Karl A. Kabarowski, Veronica L. Porubsky et al. (4 authors)
Cancer Cell International
Open Access
Published: Dec 2015
32 citations
32 citations
2071 days before retraction
Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer
Hideya Onishi, Akio Yamasaki, Makoto Kawamoto et al. (5 authors)
Cancer Letters
Published: Nov 2015
29 citations
29 citations
2072 days before retraction
Development of a Novel PET Tracer [18F]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging
Qinghua Liu, Donghui Pan, Chao Cheng et al. (14 authors)
PLoS ONE
Open Access
Published: Nov 2015
11 citations
11 citations
2097 days before retraction
Molecular biology of gynecological cancer
Kenzo Sonoda
Oncology Letters
Open Access
Published: Nov 2015
20 citations
20 citations
2097 days before retraction
The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
Angela Cho, Viive M. Howell, Emily K. Colvin
Frontiers in Oncology
Open Access
Published: Nov 2015
123 citations
123 citations
2100 days before retraction
Targeting of MMP2 activity in malignant tumors with a 68 Ga-labeled gelatinase inhibitor cyclic peptide
Qinghua Liu, Donghui Pan, Chao Cheng et al. (15 authors)
Nuclear Medicine and Biology
Published: Aug 2015
12 citations
12 citations
2187 days before retraction
Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9
Haiyu Zhang, Chunyan Hao, Yang Wang et al. (9 authors)
Molecular Carcinogenesis
Published: Jul 2015
19 citations
19 citations
2217 days before retraction
Extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 overexpression is associated with loss of hormone receptor expression and poor prognosis in endometrial cancer
Yuan Yuan, Ning Shen, Shujuan Yang et al. (5 authors)
Oncology Letters
Open Access
Published: May 2015
10 citations
10 citations
2280 days before retraction
Ovarian cancer: involvement of the matrix metalloproteinases
Linah Al-Alem, Thomas E. Curry
Reproduction
Open Access
Published: Apr 2015
104 citations
104 citations
2288 days before retraction
Paper citing The Clinical Relevance of Stromal Matrix Metallopr...
Unknown Authors
Unknown Journal
Published: Mar 2015
2346 days before retraction
The Expression of Tumor-Derived and Stromal-Derived Matrix Metalloproteinase 2 Predicted Prognosis of Ovarian Cancer
Ziyi Fu, Sujuan Xu, Ye Xu et al. (6 authors)
International Journal of Gynecological Cancer
Open Access
Published: Feb 2015
35 citations
35 citations
2356 days before retraction
Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis
Patrice Desmeules, Dominique Trudel, Stéphane Turcotte et al. (10 authors)
Human Pathology
Published: Feb 2015
22 citations
22 citations
2363 days before retraction
Noninvasive Early Biomarkers in Ovarian Cancer
Sharon O’Toole, Ancuţa Eugen, Ream Langhe et al. (13 authors)
CRC Press eBooks
Published: Jan 2015
2398 days before retraction
High-Content Analysis with Cellular and Tissue Systems Biology
Albert Gough, Timothy R. Lezon, James R. Faeder et al. (7 authors)
Elsevier eBooks
Published: Jan 2015
12 citations
12 citations
2405 days before retraction
Metabolic orchestration between cancer cells and tumor microenvironment as a co-evolutionary source of chemoresistance in ovarian cancer: A therapeutic implication
Dong Hoon Suh, Hee Seung Kim, Boyun Kim et al. (4 authors)
Biochemical Pharmacology
Published: Aug 2014
59 citations
59 citations
2534 days before retraction
The Role of the Tumor Stroma in Ovarian Cancer
Ben Davidson, Claes G. Tropé, Reuven Reich
Frontiers in Oncology
Open Access
Published: May 2014
47 citations
47 citations
2638 days before retraction
EphA2 enhances the proliferation and invasion ability of LNCaP prostate cancer cells
Peijie Chen, Yan Huang, Bo Zhang et al. (5 authors)
Oncology Letters
Open Access
Published: Apr 2014
28 citations
28 citations
2656 days before retraction
Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosis
Dominique Trudel, Patrice Desmeules, Stéphane Turcotte et al. (9 authors)
Modern Pathology
Open Access
Published: Mar 2014
29 citations
29 citations
2705 days before retraction
Clinical Relevance of Increased Endothelial and Mesothelial Expression of Proangiogenic Proteases and VEGFA in the Omentum of Patients with Metastatic Ovarian High-Grade Serous Carcinoma
Bolesław Winiarski, Nichola Cope, Mary Ellen Alexander et al. (8 authors)
Translational Oncology
Open Access
Published: Mar 2014
20 citations
20 citations
2708 days before retraction
Paper citing Patient-derived tumor reactive antibodies as diagn...
Unknown Authors
Unknown Journal
Published: Jan 2014
2741 days before retraction
Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer
Shojiro Matsushita, Hideya Onishi, Kenji Nakano et al. (9 authors)
Cancer Science
Open Access
Published: Jan 2014
52 citations
52 citations
2754 days before retraction
Correlation of survivin and mmp9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas
Fatmagül Çabuk, Seyran Yiğit, Lütfiye Demir et al. (5 authors)
Turkish Journal of Pathology
Open Access
Published: Jan 2014
7 citations
7 citations
2770 days before retraction
Immunohistochemical expression of MMP-14 and MMP-2, and MMP-2 activity during human ovarian follicular development
M. Caroline Vos, Anneke A. van der Wurff, Jessie TJ Last et al. (7 authors)
Reproductive Biology and Endocrinology
Open Access
Published: Jan 2014
28 citations
28 citations
2770 days before retraction
The correlation between immunohistochemical expression of MMP-2 and the prognosis of epithelial ovarian cancer
Tekin Ekinci, Pelin Özün Özbay, Seyran Yiğit et al. (6 authors)
Ginekologia Polska
Open Access
Published: Jan 2014
16 citations
16 citations
2770 days before retraction
Correlation of Survivin and MMP9 Expressions with Prognosis and Clinicopathological Parameters in Surface Epithelial Ovarian Carcinomas / Overin Yüzey Epitel Karsinomlarında Survivin ve MMP-9 Ekspresyonlarının Klinikopatolojik Parametrelerle ve Prognozla Korelasyonu
Fatmagül Çabuk, Seyran Yiğit, Lütfiye Demir et al. (5 authors)
Turkish Journal of Pathology
Published: Jan 2014
1 citation
1 citation
2770 days before retraction
Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition
Benoît Thibault, Magali Castells, Jean‐Pierre Delord et al. (4 authors)
Cancer and Metastasis Reviews
Published: Dec 2013
182 citations
182 citations
2783 days before retraction
Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome
Yan Wang, Yuanqing Ye, Jie Lin et al. (7 authors)
Molecular Carcinogenesis
Open Access
Published: Nov 2013
9 citations
9 citations
2813 days before retraction
The Role of p53 Protein and MMP-2 Tumor/Stromal Cells Expression on Progressive Growth of Ovarian Neoplasms
Piotr Grelewski, Julia Bar
Cancer Investigation
Published: Aug 2013
16 citations
16 citations
2923 days before retraction
Prognostic Value of MMP-9 in Ovarian Cancer: A Meta-analysis
Lina Li, Xin Zhou, Yang Gu et al. (4 authors)
Asian Pacific Journal of Cancer Prevention
Open Access
Published: Jul 2013
51 citations
51 citations
2925 days before retraction
Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity <i>via</i> NF‐κB‐dependent transcription
Deqiang Ding, Xi Peng, Junzhi Zhou et al. (5 authors)
The FASEB Journal
Published: Jul 2013
122 citations
122 citations
2931 days before retraction
Biomedical Hypothesis Generation by Text Mining and Gene Prioritization
Ingrid Petrič, Balázs Ligeti, Balázs Győrffy et al. (4 authors)
Protein and Peptide Letters
Published: Jul 2013
12 citations
12 citations
2946 days before retraction
Immunoexpression of matrix metalloproteinase–2 (MMP–2) in epithelial ovarian cancers (EOCs)
Ibrahim A. Abdelazim, Mohannad Lutfi Abu faza, Mohammed Al-Kadi
Asian Pacific Journal of Reproduction
Open Access
Published: Jun 2013
5 citations
5 citations
2984 days before retraction
Prognostic significance of matrix metalloproteinase-2 in gynecological cancer: a systemic review of the literature and meta-analysis.
Hongling Peng, Lei Liu, Xia Zhao
PubMed
Published: Apr 2013
10 citations
10 citations
3021 days before retraction
Selective Blockade of Matrix Metalloprotease-14 with a Monoclonal Antibody Abrogates Invasion, Angiogenesis, and Tumor Growth in Ovarian Cancer
Rajani Kaimal, Raid Aljumaily, Sarah L. Tressel et al. (10 authors)
Cancer Research
Open Access
Published: Feb 2013
64 citations
64 citations
3085 days before retraction
Pre-Treatment of Platinum Resistant Ovarian Cancer Cells with an MMP-9/MMP-2 Inhibitor Prior to Cisplatin Enhances Cytotoxicity as Determined by High Content Screening
Alexandros Laios, Bashir M. Mohamed, Lynne Kelly et al. (20 authors)
International Journal of Molecular Sciences
Open Access
Published: Jan 2013
31 citations
31 citations
3114 days before retraction
CLINICAL PROSPECTS OF TUMOR-ASSOCIATED PROTEASES AND THEIR TISSUE INHIBITORS INVESTIGATION IN ONCOLOGIC PATIENTS
Е. С. Герштейн, Н. Е. Кушлинский
Annals of the Russian academy of medical sciences
Open Access
Published: Jan 2013
16 citations
16 citations
3135 days before retraction
Combination of Strong MMP-2 and Weak TIMP-2 Immunostainings Is a Significant Prognostic Factor in Endometrial Carcinoma
Maria Honkavuori-Toivola, Markku Santala, Ylermi Soini et al. (5 authors)
Disease Markers
Open Access
Published: Jan 2013
21 citations
21 citations
3135 days before retraction
Molecular Profiling Predicts the Existence of Two Functionally Distinct Classes of Ovarian Cancer Stroma
Loukia N. Lili, Lilya V. Matyunina, L. DeEtte Walker et al. (5 authors)
BioMed Research International
Open Access
Published: Jan 2013
52 citations
52 citations
3135 days before retraction
КЛИНИЧЕСКИЕ ПЕРСПЕКТИВЫ ИССЛЕДОВАНИЯ АССОЦИИРОВАННЫХ С ОПУХОЛЬЮ ПРОТЕАЗ И ИХ ТКАНЕВЫХ ИНГИБИТОРОВ У ОНКОЛОГИЧЕСКИХ БОЛЬНЫХ
Е. С. Герштейн, Н. Е. Кушлинский
Вестник Российской академии медицинских наук
Published: Jan 2013
3135 days before retraction
Quick Stats
Total Citations:
171
Years Since Retraction:
4.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025